Blockade of α2-adrenoceptors by 1-(2-pyrimidinyl)-piperazine (PmP) in vivo and its relation to the activity of buspirone

This publication has 27 references indexed in Scilit:

• Specificity of Drugs as Tools in Psychopharmacology: Drugs That Interfere with Monoamine Storage
  Published by Springer Nature ,2003
• Buspirone: review of its pharmacology and current perspectives on its mechanism of action
  The American Journal of Medicine, 1986
• 1-(2-Pyrimidinyl)-Piperazine as Active Metabolite of Buspirone in Man and Rat
  Pharmacology, 1986
• Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat
  Xenobiotica, 1985
• Neurobiological mechanisms in human anxiety evidence supporting central noradrenergic hyperactivity
  Neuropharmacology, 1983
• Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidine
  Life Sciences, 1983
• Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat
  Xenobiotica, 1983
• Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine
  Life Sciences, 1982
• Noradrenergic agonists and antagonists: Effects on conditioned fear as measured by the potentiated startle paradigm
  Psychopharmacology, 1979
• On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat
  Journal of Pharmacy and Pharmacology, 1978